How Body Temperature and Calcium Levels Can Flip a Drug's Effect: Northwestern Study Reveals Hidden Dimension of Pharmacology
Key Insights
Northwestern University scientists discovered that body temperature and intracellular calcium levels can dramatically alter how drugs interact with their protein targets, sometimes reversing a drug's effect entirely.
The previously dismissed compound TPPO powerfully activated the TRPM4 (search) channel when tested at body temperature (37°C) with physiologically relevant calcium levels, overturning prior assumptions about its inactivity.
Using cryo-electron microscopy, researchers revealed that TRPM4 (search)'s drug-binding pocket changes shape depending on temperature and calcium, explaining why drug behavior is context-dependent.
A drug once dismissed as ineffective suddenly worked — when scientists tested it under more realistic conditions that mimic the human body. In a discovery that challenges fundamental assumptions in drug development, Northwestern University researchers have shown that two basic features of human biology — body temperature and calcium levels inside cells — can change how drugs interact with their targets, sometimes even flipping a drug's effect entirely.
The study, published June 9 in Nature Structural & Molecular Biology, could help explain why some drug candidates look promising in early lab tests but fail later in development, and points toward a smarter way to design more effective medicines with fewer unwanted side effects.
"Drugs don't act in isolation," said Northwestern's Wei Lü, who co-led the study with longtime collaborator Juan Du. "They act within the physiological environment of the cell. By incorporating temperature and calcium into our experiments, we uncovered drug activities that were completely invisible before."
Lü and Du are professors of molecular biosciences at Northwestern's Weinberg College of Arts and Sciences, professors of pharmacology at Northwestern University Feinberg School of Medicine, and members of Northwestern's Chemistry of Life Processes Institute. Jinhong Hu, a postdoctoral fellow in the Du and Lü labs, is the study's first author.
The problem with simplified testing conditions
In early evaluations, researchers commonly test drugs in simplified laboratory conditions — often at room temperature and in artificial chemical environments that do not necessarily reflect the realities inside the human body. But proteins are dynamic, shape-shifting molecules whose structure can change in response to their surroundings, including temperature and chemical signals like calcium. Because drugs often work by binding to proteins, even small structural shifts can dramatically change a drug's ability to work.
To better understand this connection, the Northwestern team focused on TRPM4 (search), a protein channel involved in heart rhythm, immune responses, and other essential biological functions. They tested triphenylphosphine oxide (search) (TPPO), a small synthetic molecule, on cells expressing the TRPM4 channel.
In lab tests under simplified conditions, TPPO appeared inactive, showing no effect on TRPM4 (search). But when the Northwestern team tested it at body temperature (37°C / 98.6°F) and with realistic calcium levels, the supposedly inactive compound powerfully activated the TRPM4 channel.
"This completely overturned what we thought we knew," Du said. "It shows that we may be overlooking important drug candidates simply because we are not testing them under the right conditions."
One molecule, opposite effects
In another set of experiments, the team uncovered yet another surprise. The researchers tested a compound called Necrocide-1 (search) (NC1), which is known to activate TRPM4 (search). At low calcium levels, NC1 behaved as expected, switching the protein channel on. But when calcium levels increased — as they often do when cells are stressed, injured, or diseased — the same molecule largely lost its effect.
"This tells us drug behavior is not fixed," Lü said. "The same molecule can behave very differently depending on the biological context."
Structural insights from cryo-electron microscopy
To better understand why this happens, Lü, Du, and their teams used cryo-electron microscopy, a powerful imaging technique that can visualize proteins at near-atomic resolution. The team found that TRPM4 (search) contains a flexible drug-binding region that changes shape depending on temperature and calcium levels. Those shape shifts determine which compounds can bind to the protein and what happens when they do.
"These structures show exactly how the environment reshapes the binding pocket," Du said. "Even small changes in temperature or calcium can shift how a drug interacts with the protein."
Toward environment-aware pharmacology
This work points toward a new concept that Lü and Du call "environment-aware pharmacology." Instead of designing drugs that behave the same way everywhere in the body, scientists could develop therapies that activate only under disease conditions. For example, a drug could activate only inside stressed or damaged cells where calcium reaches abnormally high levels. That could make treatments more precise while reducing adverse side effects.
According to Lü and Du, their study's implications should extend far beyond TRPM4 (search). If temperature and cellular chemistry can dramatically alter one drug target, similar hidden effects may exist across many others.
"This work highlights a missing dimension in how we study biology and develop therapeutics," Du said. "By bringing physiological conditions back into the picture, we can better understand how proteins function — and how to target them effectively."